Intravenous immunoglobulin efficacy on pembrolizumab induced severe toxic epidermal necrolysis. - Kian W; Zemel M; Elobra F; Sharb AA; Levitas D; Assabag Y; Alguayn F; Yakobson A; Rouvinov K; Fuchs L (Anti-cancer drugs, 2022)